Molecules/DISITAMAB VEDOTIN

DISITAMAB VEDOTIN

Molecular Identity

Antibody drug conjugatePhase 3

Mechanism of action: Receptor tyrosine-protein kinase erbB-2 binding agent

Molecular Formula

0.00

Molecular Weight

g/mol

DISITAMAB VEDOTINR48-ADC

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to DISITAMAB VEDOTIN

Loading drug network...